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● When a virus mutates or changes its genetic code a new strain/variant 
of the virus is formed. This has been seen with COVID-19, currently we 
know of 3 major variants, the B.1.1.7 (UK) strain, the P.1.351 (South 
Africa) strain, and the P.1 strain (Brazil). The data on these variants is 
still very limited as they are new and are currently being studied. 
● Virus’ mutate due to random changes in their genetic code, and these 
changes can happen almost anywhere and at any time. For example, the 
B.1.1.7 variant first identified in the UK has 17 changes to its genetic 
code. 
● The overall consensus on these variants is that all of them are 
transmitted more easily, most likely due to changes of the spike protein 
that binds to the ACE2 receptors. This could lead to more deaths 
simply as a result of more infections. 
● Both the South Africa and Brazil variants have shown the ability to 
prevent neutralization by antibodies from a previous infection, or in 
other words, if you previously had Covid-19 then those antibodies would 
not be as effective against these strains.
● The B.1.1.7 (UK) variant was first identified in the US in December 
2020.
This image shows the prevalence of the B.1.1.7 (UK) variant in 
the US as of 3/30/21
 This image shows the prevalence of the B.1.351 (South Africa) 
variant in the US as of 3/30/21
These new 
variants have 
slight effect on 
vaccine efficacy
 
A zoonotic disease is a virus, bacteria or other organism that is 
transmitted from animals to humans. To be classified as zoonotic, it 
must be able to replicate within a human. A reservoir organism is the 
typical organism that the zoonotic disease resides in. In most cases 
this is an animal. A host is an organism that does not typically harbor a 
particular pathogen. In most cases of zoonotic diseases the host is a 
human. A vector is a different organism that is able to transmit the 
zoonotic disease to other organisms. In most cases a vector is another 
animal. There is a special type of vector called an intermediate host. 
The intermediate host can transmit a zoonotic disease that is not 
developmentally mature. This zoonotic disease does not have the 
ability to reproduce, therefore it technically should not be considered 
a zoonotic disease. Intermediate hosts are also typically animals.
Zoonotic diseases are very common in new emerging diseases, 
but it is very difficult biologically to achieve. When exposed to new 
viruses from animals, human’s immune systems can deter most viruses. 
If the virus is able to make it past the body's viral protections then 
most viruses are not able to replicate within a human host. Most 
viruses that are able to replicate are not able to replicate in numbers 
that are able to produce disease or eventually illness. All these 
factors cause a bottleneck in the viral population that has potential to 
become zoonotic. 
What is a zoonotic disease?
Complications of a virus becoming Zoonotic
Replication of a virus is very host specific because the virus must 
navigate its way through hundreds of protein interactions. These 
interactions can be deterred by changes in pH, temperature, and even a 
simple change in amino acid in a single protein. The virus must be able to 
successfully replicate within a new host with a different environment. The 
virus must be able to utilize host proteins specific for replication including 
transcription factors, cell surface proteins, and transport proteins. If the 
virus is not complementary with the host’s proteins or a couple mutations 
away from being complementary, then the virus will not be able to 
replicate; therefore it is not considered zoonotic. 
 Viruses from the Coronaviridae family have been historically 
monitored for zoonotic potential. Most viruses in the Coronaviridae family 
only require one mutation to their surface protein to be able to utilize the 
human ACE2 receptor. Once a virus has all required mutations to infect a 
host’s cell it can begin to mutate and further adapt to the new 
environment. Humans become an alternate host when a virus becomes 
zoonotic. This virus can now replicate in the reservoir as well as within the 
host. Once the numbers of the virus increase in the first infected 
individual, then there is the possibility for the virus to spread to other 
members of the population
What animal did the COVID-19 virus come from?
It not a surprise that SARS-CoV-2 is responsible for the current pandemic of COVID-19. The SARS-Cov-2 virus is the seventh 
zoonotic virus arising from that family of viruses. There have been some claims that the virus did not come from an animal and it was made 
within a laboratory. The Coronaviruses have very similar homology except for a receptor binding domain (RBD) region that is more variable. 
This RBD is found within the spike proteins of the virus that binds with the ACE2 receptor in human cells.  The RBD region on the 
SARS-CoV-2 virus is completely unique to the that virus. The SARS-CoV-2 binds with high affinity to the ACE2 receptors in the host cell. 
Computational analysis shows that this unique RBD sequence should not have a high affinity for the ACE2 receptors, but the fact that they 
do suggests that natural selection occurred within this virus. This is good evidence to suggest the virus was not made within a laboratory, 
although that could never be proven. To think of it plainly, to manufacture this virus, a laboratory would need to take the genetics from a 
previous organism to allow it to have a high affinity for binding, but this is not the case. The researchers found that the RBS is completely 
unique to anything that had been previously found.
Many of the early cases of COVID-19 were associated with a meat market in Wuhan, China. The bat species present at Wuhan 
market was Rhinolophus affinis which when genetically sequenced has 96% similar genetic code to SARS-CoV-2. The genetic codes differed 
within the RBD. Pangolins, Manis javanica, that were illegally imported into that region of China also were proposed as a reservoir. The 
genetic code of Rhinolophus affinis are very homologous, but it is missing a polybasic cleavage site sequence unique to SARS-CoV-2. It is 
possible that either of these species could be an intermediate host for the virus. The exact reservoir organism is unknown. 
The first line represents the entire genetic sequencing of the SARS-CoV-2 virus. The pink region is what encodes 
for the spike proteins which includes the RBD region. The second line is a magnification of the spike protein 
region. As you can see by the five vertical lines within S1 subunit, most mutations occur within the RBD. 
Can our pets get COVID-19?
As of March, animals play an insignificant role in spreading SARS-CoV-2 to 
people. As previously mentioned, it is likely that either a pangolin or a bat 
initiated the spread of SARS-CoV-2 to people. Those who are concerned 
that they themselves may have COVID-19, should refrain from having 
contact with animals, both domestic and wild. This is due to the few cases 
that have occurred in animals. As mentioned, the high binding affinity for 
SARS-CoV-2 to our ACE2 receptor is responsible for Covid-19 infections in 
our bodies. In other species, this is also the case. We can attribute the 
infections found in animals to the ability for their ACE2 receptor to bind to 
SARS-CoV-2 leading to COVID-19 cases being documented in a few animals. 
Using an ELISA assay and RNA analysis the presence of SARS-CoV-2 in the 
animal hosts was evaluated. It has been found that cats, civets, camels, 
horses, sheep and rabbits can be infected with COVID-19 as their ACE2 
receptors bind to the virus very similarly to ours in a laboratory setting. 
Though there have been a few cases of COVID-19 occurring in dogs, and 
this is still being evaluated to determine why. While these dogs can have 
symptoms when infected, their ACE2 receptors bind with a weaker affinity 
to SARS-CoV-2, making them a less suitable host for the virus. This means 
that while dogs may shed the virus, they are far less likely to spread it. 
Animals such as pigs, chickens, mice, guinea pigs and ducks do not have ACE2 
receptors that bind well to the virus and as such, they have not been shown 
to contract the virus in a laboratory setting. As such, it is very possible that 
domestic animals can become infected with SARS-CoV-2, though how they 
affect the transmission to humans is still under review.
A HADDOCK score ranks the molecule interactions between 
proteins, therefore binding affinity. Species shown in red have 
low binding affinity, Species in blue have higher binding affinity, 
and species in black need to undergo more testing.
What animals have been infected? 
There have been minimal positive dogs and cat cases (U.S. - 
67 cats, 47 dogs) as of february. Various minks and one 
ferret  did contract Covid-19. Ferrets are often used as 
animal models for respiratory diseases seen in animals 
because their anatomy is similar. Ferrets are often 
recipients of viral diseases such as the common flu that 
their owners contract and pass on. Additionally, several 
large animals, including lions, tigers, pumas, snow leopards 
and gorillas in zoos have contracted Covid-19 from humans 
and displayed symptoms. Unfortunately, there is no cure for 
these animals, and the only care that can be provided is 
palliative care and quarantine. 
Ferret lungs(above) and human lungs 
(below) have the same number of lung 
lobes as well as main bronchial patterns.
This project is a part of an outreach project to thank the 
Geneseo community for making Geneseo such a great 
place. This will be reproduced as part of a booklet that 
will be provided for the community to promote science. 
We would appreciate any feedback on our poster!
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